Carbamazepine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
60290-059 -
Package NDC
60290-059-01 -
Package NDC
60290-059-02 -
Application number
ANDA216594 -
SPL ID
5e7d0501-07b8-8664-e063-6394a90a7e70 -
SPL set ID
48080efd-1781-4585-83f8-c43957ac63b3 -
UNII
33CM23913M -
RxCUI
199378 -
RxCUI
402505 -
RxCUI
402506
What the source publishes
- Labeler
- Umedica Laboratories USA Inc.
- Active ingredients
- Carbamazepine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Carbamazepine",
"splId": "5e7d0501-07b8-8664-e063-6394a90a7e70",
"labels": [
{
"setId": "48080efd-1781-4585-83f8-c43957ac63b3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48080efd-1781-4585-83f8-c43957ac63b3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=48080efd-1781-4585-83f8-c43957ac63b3"
}
],
"routes": [
"ORAL"
],
"labeler": "Umedica Laboratories USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-059-01)",
"package_ndc": "60290-059-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220820"
},
{
"sample": false,
"description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (60290-059-02)",
"package_ndc": "60290-059-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20220820"
}
],
"productId": "60290-059_5e7d0501-07b8-8664-e063-6394a90a7e70",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "60290-059",
"deaSchedule": null,
"genericName": "Carbamazepine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARBAMAZEPINE",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA216594",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220820",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486",
"N0000175751",
"N0000185506",
"N0000191266",
"N0000187064",
"N0000185507",
"N0000185607"
],
"upc": [
"0360290058014",
"0360290058021",
"0360290060024",
"0360290059028"
],
"unii": [
"33CM23913M"
],
"rxcui": [
"199378",
"402505",
"402506"
],
"spl_set_id": [
"48080efd-1781-4585-83f8-c43957ac63b3"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Mood Stabilizer [EPC]"
],
"pharm_class_moa": [
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 1A2 Inducers [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]",
"Cytochrome P450 2C9 Inducers [MoA]",
"Cytochrome P450 2C19 Inducers [MoA]"
],
"manufacturer_name": [
"Umedica Laboratories USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:60290-059_5e7d0501-07b8-8664-e063-6394a90a7e70"